Mutlu, H. And Buyukcelik, A. 2015. The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.21, no.4 , 310-312.

Mutlu, H., & Buyukcelik, A., (2015). The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.21, no.4, 310-312.

Mutlu, HASAN, And Abdullah Buyukcelik. "The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.21, no.4, 310-312, 2015

Mutlu, HASAN And Buyukcelik, Abdullah. "The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.21, no.4, pp.310-312, 2015

Mutlu, H. And Buyukcelik, A. (2015) . "The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.21, no.4, pp.310-312.

@article{article, author={HASAN MUTLU And author={Abdullah Buyukcelik}, title={The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2015, pages={310-312} }